In:
International Journal of Cancer, Wiley, Vol. 136, No. 8 ( 2015-04-15), p. 1881-1887
Kurzfassung:
What's new? Patients with chronic myeloid leukemia (CML) are immunosuppressed but their risk of developing active tuberculosis has not been assessed. This study from Taiwan using a nationwide population‐based dataset demonstrates that the incidence of tuberculosis is significantly higher in patients with CML (adjusted hazard ration of 3.76), especially in those of male sex, older age and receiving either stem cell transplantation or interferon‐α treatment. Treatment with tyrosine kinase inhibitors did not increase the risk. The authors recommend intensified tuberculosis screening in CML patients, especially those with increased risk.
Materialart:
Online-Ressource
ISSN:
0020-7136
,
1097-0215
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2015
ZDB Id:
218257-9
ZDB Id:
1474822-8
